- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in D.C., Maryland, North Carolina, South Carolina and Virginia.
In “Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics,” the objectives of this presentation are to understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes, discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder, and review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder.

Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS

Amica Simmons-Yon, PharmD, PhD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Miranda Fisher, PhD
Medical Science Liaison
Speakers Dennis Sholler, PhD; Amica Simmons-Yon, PharmD, PhD; and Miranda Fisher, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.